Professional Documents
Culture Documents
w1 Pharmacology
w1 Pharmacology
TERMINOLOGIES
Medication A substance administered for the diagnosis, cure, treatment, or relief of
a symptom or for prevention of disease.
1. Medication and drug are generally used interchangeably. The
term drug also has the connotation of an illicitly obtained
substance such as heroin, cocaine, or amphetamines.
2. One drug can have four kinds of names:
• Generic name
o Assigned by the United States Adopted Names
(USAN) Council and is used throughout the
drug’s lifetime.
• Trade name (or brand name)
o The name given by the drug manufacturer and
identifies it as property of that company.
o Usually short and easy to remember.
• Official name
o The name under which a drug is listed in one of 1
the official publications.
• Chemical name
o The name by which a chemist knows it
o This name describes the constituents of the drug
precisely.
Prescription A written direction for the preparation and administration of a drug.
Pharmacology The study of drugs and their effect on living systems.
Pharmacy • The art of preparing, compounding, and dispensing drugs.
• The place where drugs are prepared and dispensed.
Pharmacist A licensed health professional who prepares, dispenses and advises on
medicinal drugs.
Clinical pharmacist A specialist who often guides the primary care provider in prescribing
drugs.
Pharmacy technician A member of the health team who in some states administers drugs to
clients.
Pharmacologist A scientist that researches new drugs.
Pharmacopoeia • Also spelled as pharmacopeia.
• A book containing a list of products used in medicine, with
descriptions of the product, chemical tests for determining
identity and purity, and formulas and prescriptions.
PHARMACOKINETICS
• Pharmacokinetic refers to what the body does to a drug.
• It is the study of the absorption, distribution,
biotransformation, and excretion of drugs.
1. ABSORPTION
• Absorption is the processes of entry of a drug
into the systemic circulation from the site of its administration.
• Bioavailability
o The rate and extent to which an administered drug reaches the systemic
circulation.
o For example, if 100 mg of a drug is administered orally and 70 mg is
2
absorbed unchanged, the bioavailability is 0.7 or 70%.
o Factors influencing bioavailability
▪ First-pass metabolism
• When a drug is
absorbed from the GI
tract, it enters the
portal circulation
before entering the
systemic circulation.
▪ Solubility of the drug
• Aqueous solution mix more readily than those in oily
solution.
• Most drug absorption occurs in small intestine.
• The rate and extent of absorption depend on:
o The environment where the drug is absorbed
o Chemical characteristics of the drug
o The route of administration (which influences bioavailability).
• Factors influencing absorption
o Food
▪ Can delay the dissolution and absorption of some drugs as well as
their passage into the small intestine.
▪ Can also combine with molecules of certain drugs, thereby changing
their molecular structure and subsequently inhibiting or preventing
their absorption.
o Acid in the stomach
▪ Acidity can vary according to the time of day, foods ingested, use of
antacid medications, and the age of the client.
▪ Some drugs do not dissolve or have limited ability to dissolve in the
GI fluids, decreasing their absorption into the bloodstream.
o Blood flow to the absorption site
▪ Nitroglycerin is administered under the tongue where it is absorbed
into the blood vessels that carry it directly to the heart.
• If swallowed, this drug will be absorbed into the bloodstream
and carried to the liver, where it will be destroyed.
▪ Route of choice for rapid action is intravascular administration 3
(e.g., IV)
• It does not involve absorption thus, there is no loss of drug.
Bioavailability = 100%
▪ Intramuscular (IM)route is the next most rapid route due to the
highly vascular nature of muscle tissue.
▪ Absorption from subcutaneous tissue is slower due to pooper blood
supply than muscle tissue.
o Application of heat
▪ Increases blood flow to the area, thus increase rate of absorption of
drug.
▪ Cold slow down absorption of drug.
o Vasoconstrictor
▪ Epinephrine slow down the absorption of other drugs.
o Oil
▪ Some drugs intended to be absorbed slowly are suspended in a low-
solubility medium.
o Route
▪ The absorption of drugs from the rectum into the bloodstream tends
to be unpredictable. Thus, this route is normally used when other
routes are unavailable or when the intended action is localized to the
rectum or sigmoid colon.
2. DISTRIBUTION
• The transportation of a drug from its site of absorption to its site of action.
• When a drug enters the bloodstream, it is carried to the most vascular organs—that
is, liver, kidneys, and brain.
• Body areas with lower blood supply like skin receive the drug later.
3. METABOLISM
• Also called detoxification or biotransformation.
• Biotransformation is the metabolic conversion of drug molecules to more water-
soluble metabolites or less active form that are more readily excreted.
• Most biotransformation takes place in the liver, where many drug-metabolizing
enzymes in the cells detoxify the drugs.
• Metabolites is the product of biotransformation.
4
o Two types:
▪ Active metabolite has a pharmacologic action.
▪ Inactive metabolite does not have pharmacologic action.
• Biotransformation may be altered if a person is very young, is older, or has an
unhealthy liver.
• Half-life
o The time interval required for the body’s elimination processes to reduce
the concentration of the drug in the body by one-half.
o Example:
▪ If a drug’s half-life is 8 hours, then the amount of drug in the body
is as follows:
• Initially: 100%
• After 8 hours: 50%
• After 16 hours: 25%
• After 24 hours: 12.5%
• After 32 hours: 6.25%
o Because the purpose of most drug therapy is to maintain a constant drug
level in the body, repeated doses are required to maintain that level.
o Terminology
▪ Onset of action
• The time after administration when the body initially
responds to the drug
▪ Peak plasma level
• The highest plasma level achieved by a single dose when the
elimination rate of the drug equals the absorption rate
▪ Drug half-life (elimination half-life)
• The time required for the elimination process to reduce the
concentration of the drug to one-half what it was at initial
administration
▪ Plateau
• A maintained concentration of a drug in the plasma during a
series of scheduled doses
4. ELIMINATION
• The process by which metabolites and drugs are eliminated from the body.
5
• Most drug metabolites are eliminated by the kidneys in the urine.
• Some are excreted in the feces, the breath, perspiration, saliva, and breast milk.
• Older people may require smaller doses of a drug because the drug and its
metabolites may accumulate in the body.
PHARMACODYNAMICS
• The mechanism of drug action and the relationships between drug concentration and
responses in the body.
RECEPTOR
• The drug’s specific target, usually a protein located on the surface of a cell membrane or
within the cell.
• As the drug binds to the receptor, it enhances or inhibits the normal cellular function.
• The binding is usually reversible and the action of the drug terminated once the drug leaves
the receptor.
• When a drug binds to its receptor, the pharmacologic effects are either agonism or
antagonism.
o Agonist
▪ When a drug produces the same type of response as the physiological or
endogenous substance.
▪ For example:
• Epinephrine-like drugs act on the heart to increase the heart rate.
o Antagonist
▪ A drug that inhibits cell function by occupying receptor sites.
▪ It prevents natural body substances or other drugs from activating the
functions of the cell by occupying the receptor sites.
▪ For example:
• Naloxone (Narcan) is an opioid antagonist used as an antidote for
respiratory depression caused by an opioid drug.
o It competes with opioid receptor sites in the brain and
thereby prevents the opioid from binding to its receptors.
o By blocking the effect of the opioid, respiratory depression
is reversed.
• Development
o Infants
▪ Immaturity of liver and kidney require decrease dose.
o Older adults
▪ Decrease liver and kidney function lead to accumulation of the drug in the
body.
▪ Decrease circulation and gastric function that lead to decrease medication
absorption.
▪ Many meds (polypharmacy) increases interactions.
o Pregnancy
▪ Some medications may cause abnormal development of embryo
(teratogenic effect).
• Diet
o Nutrients can increase or decrease absorption or action of medication.
• Gender
o Distribution of body fat, body fluid and hormones affect medication action.
• Environment
o Environmental temperature can increase or decrease peripheral vasoconstriction
altering medication action.
o Noise can interfere with effect of sedatives and analgesics.
• Pathology
o Decrease liver or kidney function cause increase medication accumulation.
o Decrease gastric or decrease circulatory function cause decrease medication
absorption.
• Time of administration
o Increase absorption on empty stomach
o With food to decrease gastrointestinal distress
o Circadian and sleep cycles can affect response
• Body weight
o Dose calculated by client’s weight or body surface area
• Genetic and ethnic
o Usual dose may be toxic
o Herbal treatments may interfere with medication therapy
o Asians may need decrease dose of antipsychotic and antianxiety medications due to 7
slower metabolism of these drugs
o African Americans may need to increase dose of antihypertensives
• Psychological issues
o Client’s positive and negative expectations can increase or decrease response.
MEDICATION ADMINISTRATION
TEN RIGHTS OF MEDICATION ADMINISTRATION
1. Right Medication
• Double check the prescription, medication and expiry date on the medicine.
• Does the medication ordered match the medication you are preparing?
• Is the medication appropriate for the client? Appropriateness is determined by
obtaining a complete medical history, an updated medication history, and any
pertinent laboratory studies.
• Knowing the specifics of the ordered medication is also necessary in determining
suitability for the client.
2. Right Client
• Confirm the patient by a minimum of two identifiers
o Their name
o Check the armband
o Compare a photograph on file to the client
3. Right Dose
• Confirm the dosage using a current drug reference
• If unconfirmed, calculate the dosage and double check with another nurse or doctor
4. Right Time
• To achieve a therapeutic blood level, medication must be given at the right time
• The common rule of thumb for most medicines is to give the medicine within 30
minutes of the scheduled time
• Check with the patient when they had their last dosage
5. Right Route
• Ensure the appropriateness of the route ordered and whether the patient can
receive the medication from this route
6. Right Documentation
• Document the administration of the medication as soon as it has been administered 8
7. Right Client Education
• Explain to the client why they receive the medication, what to expect, and if there
are any precautions
8. Right to Refuse
• Adult clients have the right to refuse any medication
• The nurse’s role is to ensure that the client is fully informed of the potential
consequences of refusal and to communicate the client’s refusal to the health care
provider
9. Right Assessment
• Some medications require specific assessments prior to administration (e.g., apical
pulse, blood pressure, lab results)
10. Right Evaluation
• Check if the effect of the medication to the client, if it was a desired effect or no, or
are there any side effects or adverse effect.
CLIENT TEACHING IN MEDICATION ADMINISTRATION
• Make sure the client is not hypersensitive to the drug being given.
• Make sure your client does not have a known allergy to the medication.
• Get a complete history from your client. Look at all medications the client is taking and 9
make sure there are no adverse drug or food interactions.
• Know why you are giving the drug and what the expected response is.
• Are there any labs or vital signs you need to check prior to administration?
• Document and report any adverse effects and counteract these effects appropriately.
• Find out if the client is pregnant or breast-feeding, as most medications are contraindicated
in these women.
SUBLINGUAL ROUTE
ADVANTAGE DISADVANTAGE
More potent than oral route because drug If swallowed, drug may be inactivated by
directly enters the blood and bypasses the liver gastric juice
Usually least expensive Drug must remain under tongue until
dissolved and absorbed.
Safe, does not break skin barrier May cause stinging or irritation of the mucous
membranes
Administration usually does not cause stress Drug is rapidly absorbed into the bloodstream
Drug can be administered for local effect
Most convenient
BUCCAL ROUTE
ADVANTAGE DISADVANTAGE
More potent than oral route because drug If swallowed, drug may be inactivated by
directly enters the blood and bypasses the liver gastric juice
Usually least expensive Drug must remain under tongue until
dissolved and absorbed.
Safe, does not break skin barrier May cause stinging or irritation of the mucous
membranes
Administration usually does not cause stress Drug is rapidly absorbed into the bloodstream 14
PARENTERAL ROUTE
• This route introduces drugs directly across the body’s barrier defenses into the systemic
circulation.
• Used for drugs that are poorly absorbed from the GI tract and for agents that are unstable
in GI tract.
• Used also for treatment of unconscious clients and under circumstances that require a rapid
onset of action.
• These routes have the highest bioavailability and not subject to first-pass metabolism or
harsh GI environment.
• Parenteral administration provides the most control over the actual dose of drug delivered
to the body.
• Four major parenteral routes
o Intravenous (IV) route
▪ Solution injected into intravascular
compartment via a vein.
▪ Drugs administered are irreversible.
▪ This route may cause pain, fear, local tissue damage and infections.
▪ Immediate onset
▪ Most common parenteral route.
▪ It permits a rapid effect and maximum degree of control over the circulating
levels of the drug.
▪ When injected as a bolus, the full amount of a drug is delivered to the
systemic circulation almost immediately.
▪ The same dose is also may be administered as an IV infusion during a longer
time, resulting in a decrease in the peak plasma concentration and an
increase in the time the drug is present in the circulation. 15
▪ IV injection is advantageous for administering chemicals that may cause
irritation when administered via other routes because the substance is
rapidly diluted by the blood.
ADVANTAGE DISADVANTAGE
Rapid effect Limited to highly soluble drugs
Valuable in emergency situations Drug distribution inhibited by poor circulation
Ideal for high molecular weight proteins and Most substances must be slowly injected
peptide drugs
Ideal if dosed in large volumes Unsuitable for oily substances
Suitable for irritating substances and complex Injected medication cannot be recalled by
mixtures strategies such as by binding to activated
charcoal.
May introduce bacteria and other infective
particles through contamination at the site of
injection.
May also precipitate blood constituents,
induce hemolysis, or cause other adverse
reaction by the too rapid delivery of high
concentrations of drug to the plasma and
tissues.
ADVANTAGE DISADVANTAGE
Can administer larger volume than Can produce anxiety
subcutaneous
Drug is rapidly absorbed Breaks skin barrier, more tissue damage than
subcutaneous
Suitable if drug volume is moderate Affects certain lab tests (creatine kinase)
Suitable for oily vehicles and certain irritating Can cause intramuscular hemorrhage
substances
Used when oral route is contraindicated; more Requires adequate peripheral circulation
rapidly absorbed than oral, topical, or
subcutaneous
o Subcutaneous (SC) route
▪ Injected in tissue just below skin
▪ Onset 3-20min
▪ Volume less than or equal to 1mL
▪ Like IM injection, it requires absorption
via simple diffusion and is somewhat slower
than the IV route.
▪ SC injection minimizes the risk of hemolysis or thrombosis associated with
IV injection and may provide constant, slow and sustained effect.
▪ This route should not be used with drugs that cause tissue irritation because
severe pain and necrosis may occur.
▪ Nursing care
• Use standard precautions
• Use sterile technique
• Rotate injection sites
• Landmark sites
ADVANTAGE DISADVANTAGE 17
Absorption is slower (an advantage for insulin Must involve sterile technique because breaks
and heparin administration) skin barrier
Faster than oral More expensive than oral
Can administer only small volume
Some drugs can irritate tissues and cause pain
Can produce anxiety
Breaks skin barrier
INHALATION ROUTE
• Medications are dispersed through aerosolized solution or powder that penetrates airways
rapidly promoting absorption
• May be oral or nasal inhalation
• Provide rapid delivery of drug across the large surface of area of the mucus membranes of
the respiratory tract and pulmonary epithelium, producing an effect as rapidly as IV
injection.
• Used for drugs that are gases and those that can be dispersed in an aerosol.
• This route is effective and convenient for clients with respiratory complaints because the
drug is delivered directly to the site of action, thereby minimizing systemic side effects.
• Types
▪ Metered-dose inhaler (MDI)
▪ The MDI is a small, portable
18
self-contained drug device combination
that dispenses multiple doses by a metered
value.
TOPICAL ROUTE
ADVANTAGE DISADVANTAGE 19
Few side effects Drug can enter body through abrasions and
cause systemic effects
Leaves residue on the skin that may soil clothes
• Via skin
• Prolonged systemic effect
• Achieves systemic effects by application of drugs to the skin, usually via transdermal patch.
• The rate of absorption can vary markedly, depending
on physical characteristics of the skin
at the site of application as well as the lipid
solubility of the drug.
• This route most often used for the sustained
delivery of drugs.
• For example, nitroglycerin, an antianginal drug.
ADVANTAGE DISADVANTAGE
Prolonged systemic effect Rate of delivery may be variable
Few side effects Some clients are allergic to patches, which can
Avoids GI absorption problems cause irritation
Onset of drug action faster than oral
Convenient and painless
RECTAL ROUTE
ADVANTAGE DISADVANTAGE
Can be used when drug has objectionable taste May be perceived as unpleasant by the client
or odor
Provides a local therapeutic effect Dose absorbed is unpredictable
Drug released at slow, steady rate Limited use
Bypasses destruction by stomach acid Drugs may irritate the rectal mucosa
Ideal if drug causes vomiting
TYPES OF DRUG PREPARATIONS
TYPES OF DRUG PREPARATIONS
Aerosol spray or foam A liquid, powder, or foam deposited in a thin layer on the skin by
air pressure
Aqueous solution One or more drugs dissolved in water
Aqueous suspension One or more drugs finely divided in a liquid such as water
Caplet A solid form, shaped like a capsule, coated and easily swallowed
Capsule A gelatinous container to hold a drug in powder, liquid, or oil
form
Cream A non-greasy, semisolid preparation used on the skin
Elixir A sweetened and aromatic solution of alcohol used as a vehicle
for medicinal agents
Extract A concentrated form of a drug made from vegetables or animals
Gel or jelly A clear or translucent semisolid that liquefies when applied to the
skin
Liniment A medication mixed with alcohol, oil, or soapy emollient and
applied to the skin
21
Lotion A medication in a liquid suspension applied to the skin
Lozenge (troche) A flat, round, or oval preparation that dissolves and releases a
drug when held in the mouth
Ointment (salve, unction) A semisolid preparation of one or more drugs used for
application to the skin and mucous membrane
Paste A preparation like an ointment, but thicker and stiff, that
penetrates the skin less than an ointment
Pill One or more drugs mixed with a cohesive material, in oval,
round, or flattened shapes
Powder A finely ground drug or drugs; some are used internally, others
externally
Suppository One or several drugs mixed with a firm base such as gelatin and
shaped for insertion into the body (e.g., the rectum); the base
dissolves gradually at body temperature, releasing the drug
Syrup An aqueous solution of sugar often used to disguise unpleasant-
tasting drugs
Tablet A powdered drug compressed into a hard small disk; some are
readily broken along a scored line; others are enteric coated to
prevent them from dissolving in the stomach
Tincture An alcoholic or water-and-alcohol solution prepared from drugs
derived from plants
Transdermal patch A semipermeable membrane shaped in the form of a disk or
patch that contains a drug to be absorbed through the skin over
a long period of time
MEDICATION ORDERS
TYPES OF MEDICATION ORDERS
• Stat order
o The medication is to be given immediately and only once.
• Single order
o Also known as one-time order is for medication to be given once at a specified time.
• Standing order
o May or may not have a termination date.
o May be carried out indefinitely until an order is written to cancel it, or it may be
carried out for a specified number of days
• PRN order
o Also known as ‘as-needed order’, permits the nurse to give a medication when, in
the nurse’s judgment, the client requires it.
SEVEN ESSENTIAL PARTS OF MEDICATION ORDER
METRIC SYSTEM
ABBREVIATIONS EQUIVALENTS
meter: m 1 mcg = 0.000001 g
liter: L 1 mg = 1000 mcg or 0.001 g
milliliter: mL 1 g = 1000 mg
kilogram: kg 1 kg = 1000 g
gram: g 1 kg = 2.2 lb
milligram: mg 1 mL = 0.001 L 24
microgram: mcg
CALCULATING DOSAGES
BASIC FORMULA
The basic formula for calculating drug dosages is commonly used and easy to remember:
Formula = DxQ
H
• Examples
1. Order: Erythromycin 500 mg
On hand: 250 mg in 5 mL
D = 500 mg H = 250 mg Q = 5 mL 25
500 mg x 5 mL = 2,500 = 10 mL
250 mg 250
1000 mcg = 1 mg
60 mg = 1 gr
20 pounds x 1 kg = 9 kg
2.2 pounds
20 mg x 9 kg = 180 mg/day
1 kg
FLOW RATE
INFUSION RATE
• Example:
• FLOW RATE
o Ancef 1gm in 100 mL normal saline to be infused over 30 minutes. You have
macrodrip tubing with a drop factor of 10 gtts/mL. How many drops per min
to be infuse?
100 mL x 10 gtts = 33.3 or 33 gtts/min
30 min
• INFUSION RATE
o There are 250 mL of D5W infusing at 33 gtt/min on IV tubing calibrated at 10
gtt/mL. Calculate the infusion time.
250 mL / (33 gtts/min x 60 min) = 250/ (1,980)
10 gtts/mL 10
0.26 x 60 = 16 min
1. Always check with the pharmacist to see if the client’s medications come in a liquid form.
33
These are less likely to cause tube obstruction.
2. If there is no liquid form, check if the drug can be crushed. Enteric-coated, sustained-action,
buccal, and sublingual medications should never be crushed.
3. Liquid medication must be further diluted with sterile water to smoothly flow to the tube.
4. Crush a tablet into a fine powder and dissolve in at least 30 mL of warm sterile water
because cold liquids may cause client discomfort.
5. Do not use tap water it often contains chemical contaminants that might interact with the
drug. Use sterile water instead.
6. Open hard gelatin capsules and mix the powder with sterile water.
7. Do not administer whole or undissolved medications, it will clog the tube.
8. Assess tube placement prior to administration of medications.
9. Before giving the medication, aspirate all the stomach contents and measure the residual
volume.
10. Administer the medication
o Remove the plunger from the syringe and connect the syringe to a pinched or
kinked tube. Pinching or kinking the tube prevents excess air from entering the
stomach and causing distention.
o For adult, put 15 to 30 mL (for children 5 to 10 mL) of sterile water into the syringe
barrel to flush the tube before administering the first medication. Raise or lower
the barrel of the syringe to adjust the flow as needed. Pinch or clamp the tubing
before all the water is instilled to avoid excess air entering the stomach.
o Pour liquid or dissolved medication into the syringe barrel and allow to flow by
gravity into the enteral tube.
o If you are giving several medications, administer each one separately and flush with
at least 15 to 30 mL (5 mL for children) of tap water between each medication.
o Once done, flush with another 15 to 30 mL (5 to 10 mL for children) of warm water
to clear the tube.
11. If the tube is connected to suction, disconnect the suction and keep the tube clamped for
20 to 30 minutes after giving the medication to enhance absorption.
PARENTERAL MEDICATIONS
• Nurses give parenteral medications intradermally (ID), subcutaneously, intramuscularly
(IM), or intravenously (IV). 34
• Aseptic technique must be used to minimize the risk of infection.
• Syringe
o Parts
▪ Tip
• Connects with the needle
▪ Barrel
• Outside part where the scales are printed
▪ Plunger
• Fits inside the barrel
o The nurse should avoid letting any unsterile object touch the tip or inside of the
barrel, the shaft of the plunger, or the shaft or tip of the syringe.
o Kinds of syringe
▪ Hypodermic syringe
• Comes in 3- and 5-mL sizes
▪ Insulin syringe
• The scale is specially designed for insulin.
• A 100-unit calibrated scale intended
for use with U-100 insulin.
• The only syringe that should be used to
administer insulin.
• Have a nonremovable needle.
• Insulin pen
o An insulin injector device that looks like a pen and contains
an insulin cartridge.
o The client attaches a new
needle for each injection,
dials in a dose, inserts the
needle, and presses the
injection button to deliver the insulin.
▪ Tuberculin syringe
• Originally designed to administer tuberculin solution
35
• A narrow syringe calibrated in tenths
and hundredths of a milliliter (up
to 1 mL) on one scale and in
sixteenths of a minim (up to 1 minim) on the other scale.
• Useful in administering other drugs, particularly when small or
precise measurement is indicated.
o Factors in choosing syringe
▪ Medication
▪ Location of injection
▪ Type of tissue
• Needles
o Made of stainless steel
o A dull or damaged needle should never be used.
o Parts of needle
▪ Hub
• Fits onto the syringe
▪ Cannula, or shaft
• Attached to the hub
▪ Bevel
• The slanted part at the tip of the needle
o Three variables of needles used in injections
▪ Slant or length of the bevel
• Longer bevels
o Provide the sharpest needles and cause less discomfort.
o Commonly used for subcutaneous and intramuscular
injections.
• Short bevels
o Used for intradermal and IV injections because a long bevel
can become occluded if it rests against the side of a blood
vessel.
▪ Length of the shaft
• Varies from 1/2 to 2 inches
• Appropriate needle length is chosen according to the client’s muscle
development, the client’s weight, and the type of injection.
▪ Gauge (or diameter) of the shaft
36
• The gauge varies from #18 to #30.
• The larger the gauge number, the smaller the diameter of the shaft.
• Smaller gauges produce less tissue trauma.
• Larger gauges are necessary for viscous medications, such as
penicillin
• Prepared by withdrawing the medication from an ampule or vial into a sterile syringe, using
prefilled syringes, or by using needleless injection systems.
• Ampules
o A glass container usually designed to hold a single dose of a drug.
o Made of clear glass and has a distinctive shape with a constricted neck.
o Vary in size from 1 to 10 mL or more.
o Most ampule necks have colored marks around them for easy opening.
o The ampule must be broken at its constricted neck
o Opening ampules
▪ Plastic ampule openers are available that prevent injury from broken glass.
▪ If an ampule opener is not available
• The nurse can clean the ampule neck with an alcohol swab and,
using dry sterile gauze, snap off the top of the ampule.
• Once the ampule is broken, the fluid is aspirated into a syringe using
a filter needle or filter straw. Both prevent aspiration of any glass
particles.
• Vials
o A small glass bottle with a sealed rubber cap.
o Vials come in different sizes, from single-use vials to multiple-dose vials.
o Vial must be pierced with a needle to access the medication
o Air must be injected into a vial before the
medication can be withdrawn because there is a
vacuum within the vial that makes withdrawal
difficult.
o Powder in vials have their own diluents
however, commonly used diluents are sterile water or sterile normal saline. 38
o Make sure to follow the instructions in diluting powder in vials.
• Purpose
o To provide a medication that the client requires for allergy testing and TB
screening
12 • With the nondominant hand, pull the skin at the site until it is taut.
Taut skin allows for easier entry of the needle and less discomfort
for the client.
• Insert the tip of the needle far enough to place the bevel through
the epidermis into the dermis. The outline of the bevel should be
visible under the skin surface.
• Stabilize the syringe and needle.
• Inject the medication carefully and slowly
so that it produces a small wheal on the
skin to verify that the medication entered the
dermis
• Withdraw the needle quickly at the same angle at which it was
inserted.
• Discard the uncapped needle and attached syringe into designated
receptacles.
13 Do not massage the area. Massage can disperse the medication into the
tissue or out through the needle insertion site.
14 Remove and discard gloves
15 Wash hands
16 Circle the injection site with ink to observe for redness or induration
(hardening)
17 Record the testing material given, the time, dosage, route, site, and nursing
assessments.
18 Evaluate the condition of the site in 24 or 48 hours, depending on the test.
Measure the area of redness and induration in millimeters at the largest
diameter and document findings.
SUBCUTANEOUS INJECTIONS
• Purpose
o To provide a medication the client requires
o To allow slower absorption of a medication compared with either the intramuscular
or intravenous route.
• Lovenox is a low molecular weight heparin that is used to prevent deep venous thrombosis
(DVT).
• Procedure
o Choose an area on the abdomen at least 2 inches from the umbilicus and above the
level of the iliac crests.
o Lovenox syringes come prefilled. Check that the syringe is for the correct dosage.
Every syringe comes with a small air bubble. Do not expel the air bubble unless you
have to adjust the dose.
o Pinch an inch of the cleansed area on the abdomen to make a fold in the skin. Insert
the full length of the needle at a 90° angle into the fold of the skin.
o Press the plunger with your thumb until the syringe is empty.
o Pull the needle straight out at the same angle that it was inserted and release the
skinfold. 50
o Point the needle down and away from yourself and others and push down on the
plunger to activate the safety shield.
INTRAMUSCULAR INJECTIONS
INTRAMUSCULAR INJECTION
• Purpose
o To provide a medication the client requires.
53
ADMINISTERING INTRAMUSCULAR INJECTION
Procedure Score
1 Assessment
• Allergies to medication
• Tissue integrity of selected site
• Specific drug action and expected response
• Client’s knowledge of drug action and response
• Client’s age and weight to determine site and needle size
• Ability of client to cooperate during the injection
2 Check the label on the medication carefully to make sure that the correct
medication is being prepared
• Read the label on the medication
o When it is taken from the medication cart
o Before withdrawing the medication
o After withdrawing the medication.
• Confirm that the dose is correct.
3 Organize the equipment
4 Hand wash
5 Prepare the medication from the vial or ampule for drug withdrawal.
• Whenever feasible, change the needle on the syringe before the
injection to prevent not irritation of subcutaneous tissues as it
passes into the muscle.
6 Provide for client privacy
7 • Prior to performing the procedure, introduce self and verify the
client’s identity to ensures that the right client receives the
medication.
• Assist the client to a position depending on the site to be used to
promote relaxation of the muscle and minimizes discomfort.
• Obtain assistance in holding an uncooperative client to prevents
injury due to sudden movement after needle insertion.
8 Explain the purpose of the medication to facilitate acceptance of and
compliance with the therapy.
9 Select a site
• Avoid using sites that are tender, inflamed, or swollen and those that
have lesions 54
• Select a site that has not been used frequently to reduce the
discomfort of intramuscular injections.
• Locate the exact site for the injection.
10 Wear clean gloves.
11 Clean the site with an antiseptic swab in circular motion, start at the center
and move outward.
Transfer and hold the swab between the third and fourth fingers of your
nondominant or position the swab on the client’s skin above the intended
site.
Allow skin to dry prior to injecting medication to reduce the discomfort of
the injection.
12 Remove the needle cover and discard without contaminating the needle.
13 Use the ulnar side of the nondominant hand to pull the skin approximately
2.5 cm to the side to make it firmer and facilitates needle insertion.
14 • Holding the syringe between the thumb and forefinger pierce the
skin quickly and smoothly at a 90° angle to lessen client’s
discomfort. Insert the needle into the muscle.
• Hold the barrel of the syringe steady with your nondominant hand
and aspirate by pulling back on the plunger with your dominant
hand.
• If blood appears in the syringe, withdraw the needle, discard the
syringe, and prepare a new injection.
• If blood does not appear, inject the medication steadily and slowly
while holding the syringe steady to promote comfort and allow time
for tissue to expand and begin absorption of the medication
15 After injection, wait 10 seconds
• Withdraw the needle smoothly at the same angle of insertion to
minimize tissue injury.
• Release the skin.
• Apply gentle pressure at the site with a dry sponge.
o It is not necessary to massage the area at the site of injection
to prevent leakage of medication from the site and result in
irritation.
• If bleeding occurs, apply pressure with a dry sterile gauze until it 55
stops.
16 Discard the uncapped needle and attached syringe into the proper
receptacle.
17 Remove and discard gloves, wash hands.
18 • Document the time of administration, drug name, dose, route, and
the client’s reactions.
• Assess the effectiveness of the medication at the time it is expected
to act.
19 Follow-up:
• Desired effect (e.g., relief of pain or vomiting)
• Adverse reactions or side effects
• Local skin or tissue reactions at injection site (e.g., redness,
swelling, pain, or other evidence of tissue damage).
• Relate to previous findings, if available.
• Report significant deviation from normal to the primary care
provider.
INTRAMUSCULAR INJECTION CONSIDERATIONS
• Infants
o The vastus lateralis site is recommended for intramuscular injections for infants.
There are no major blood vessels or nerves in this area, and it is the infant’s largest
muscle mass.
o Obtain assistance to immobilize an infant or young child.
▪ The parent may hold the child to prevent accidental injury during the
procedure.
• Children
o Use needles that will place medication in the main muscle mass.
o The vastus lateralis is recommended as the site of choice for toddlers and children.
o For the older child and adolescent, the recommended sites are ventrogluteal or
deltoid. Ask which arm they would like the injection in.
• Older adults
o Older clients may have a decreased muscle mass or muscle atrophy. A shorter
needle may be needed.
o Absorption of medication may occur more quickly than expected.
56
INTRAVENOUS MEDICATIONS
• Purpose
o To provide and maintain a constant level of a medication in the blood
o To administer well-diluted medications at a continuous and slow rate
• Piggyback alignment
o A second set connects the second container to the tubing of the primary container
at the upper port.
o Used solely for intermittent drug administration. 60
• Small fluid containers (100 to 150 mL in size) attached below the primary infusion
container so that the medication is administered through the
client’s IV line.
• Volume-control sets are frequently used to infuse
solutions into children and older clients when the volume
administered is critical and must be carefully monitored.
• Nursing care
o Withdraw the required dose of the medication into a syringe.
o Ensure that there is sufficient fluid in the volume-control fluid
chamber to dilute the medication.
o Close the inflow to the fluid chamber by adjusting the upper roller or slide clamp
above the fluid chamber; also ensure that the clamp on the air vent of the chamber
is open.
o Clean the medication port on the volume-control fluid chamber with an antiseptic
swab.
61
o Inject the medication into the port of the partially filled volume- control set.
o Gently rotate the fluid chamber until the fluid is well mixed.
o Open the line’s upper clamp, and regulate the flow by adjusting the lower roller or
slide clamp below the fluid chamber.
o Attach a medication label to the volume-control fluid chamber.
o Document relevant data, and monitor the client and the infusion.
INTRAVENOUS PUSH
• Purpose
o To achieve immediate and maximum effects of a medication
TOPICAL MEDICATIONS
• Applied locally to the skin or to mucous membranes in areas such as the eye, external ear
canal, nose, vagina, and rectum.
TRANSDERMAL PATCH
• Nursing care
o Assessed for allergies to the drug and to materials in the patch before the patch is
applied.
o Applied to a hairless, clean area of skin that is not subject to excessive movement
or wrinkling (example is trunk or lower abdomen)
o Patches should not be applied to areas with cuts, burns, or abrasions, or on distal
parts of extremities
o Patch containing estrogen or nicotine should not apply the patch to the breasts.
o The nurse should wear gloves when applying a transdermal patch to avoid getting
any of the medication on his or her skin, which can result in the nurse receiving the
effect of the medication.
o Use site indicated by manufacturer (chest, upper arms, anterior thighs); rotate sites
o Upon removal, any slight reddening of the skin usually disappears within a few
hours.
o All applications should be changed regularly to prevent local irritation.
o Successive application should be placed on a different site.
o The transdermal patch should be dated, timed, and initialed by the nurse before it
is applied to the client.
o Duplication of patches may cause adverse reactions. Remove the old patch and
66
clean the skin thoroughly before applying a new one.
o When removed, they should be folded with the medication side to the inside, put
into a closed container, and kept out of reach of children and pets. Because if it is
not properly discarded, it may cause effects from any drug remaining on the patch.
OPHTHALMIC MEDICATION
• Purpose
o To provide an eye medication the client requires to treat an infection or for other
reasons
ADMINISTERING OPHTHALMIC INSTILLATIONS
Procedure Score
1 Assessment
• Appearance of eye and surrounding structures for lesions, exudate,
erythema, or swelling
• The location and nature of any discharge, lacrimation, and swelling
of the eyelids or of the lacrimal gland
• Client complaints (e.g., itching, burning pain, blurred vision, and
photophobia)
• Client behavior (e.g., squinting, blinking excessively, frowning, or
rubbing the eyes).
2 • Check medication: drug name, dose, and strength.
• Confirm the prescribed frequency of the instillation and which eye is
to be treated
• Check client allergy
• Know the reason why the client is receiving the medication, the drug
classification, contraindications, usual dose range, side effects, and
nursing considerations for administering and evaluating the 67
intended outcomes of the medication.
3 Compare the label on the medication tube or bottle with the medication
record and check the expiration date
4 Introduce self to the client
Verify the client’s identity to ensure that the right client receives the right
medication
Explain to the client what you are going to do, why it is necessary, and how
he or she can participate.
5 Wash hands
6 Provide privacy
7 Assist the client to a comfortable position
8 Apply clean gloves
Use sterile cotton balls moistened with sterile irrigating solution or sterile
normal saline, and wipe from the inner canthus to the outer canthus to
prevents contamination of the other eye and the lacrimal duct.
9 Check the ophthalmic preparation for the name, strength, and number of
drops if a liquid is used to prevent a medication error.
10 Dropper
• Draw the correct number of drops into the shaft of the dropper
Ointment
• Discard the first bead because it is considered to be contaminated.
11 • Instruct the client to look up to the ceiling because the person is less
likely to blink if looking up.
• Give the client a dry sterile absorbent sponge to press on the
nasolacrimal duct after a liquid instillation to prevent systemic
absorption or to wipe excess ointment from the eyelashes after an
ointment is instilled.
• Expose the lower conjunctival sac by placing the thumb or fingers of
your nondominant hand on the client’s cheekbone just below the eye
and gently drawing down the skin on the cheek to minimizes the
possibility of touching the cornea, avoids putting any pressure on the
eyeball, and prevents the person from blinking or squinting.
• Holding the medication in the dominant hand, place hand on client’s
forehead to stabilize hand
• Approach the eye from the side and instill the
68
correct number of drops onto the outer third
of the lower conjunctival sac. Hold the dropper
1 to 2 cm above the sac because the client is less likely to blink if a
side approach is used. When instilled into the conjunctival sac, drops
will not harm the cornea as they might if dropped directly on it. The
dropper must not touch the sac or the cornea.
• Holding the tube above the lower conjunctival sac, squeeze ointment
from the tube into the lower conjunctival sac from the inner canthus
outward.
• Instruct the client to close the eyelids but not to
squeeze them shut. Closing the eye, spreads the
medication over the eyeball. Squeezing can injure
the eye and push out the medication.
12 For liquid medications, press firmly or have the client press firmly on the
nasolacrimal duct for at least 30 seconds. Pressing on the nasolacrimal duct
prevents the medication from running out of the eye and down the duct,
preventing systemic absorption.
13 Irrigation
• Place absorbent pads under the head, neck, and shoulders.
• Place an emesis basin next to the eye to catch drainage.
• Expose the lower conjunctival sac. Or, to irrigate in stages:
o First hold the lower lid down, then hold the upper lid up.
o Exert pressure on the bony prominences of the cheekbone
and beneath the eyebrow when holding the eyelids to
prevents reflex blinking. Exerting pressure on the bony
prominences minimizes the possibility of pressing the eyeball
and causing discomfort.
o Fill and hold the eye irrigator about 2.5 cm above the eye. At
this height, the pressure of the solution will not damage the
eye tissue, and the irrigator will not touch the eye.
• Irrigate the eye, directing the solution onto the lower conjunctival
sac and from the inner canthus to the outer canthus to prevent
possible injury to the cornea and prevents fluid and contaminants
from flowing down the nasolacrimal duct.
• Irrigate until the solution leaving the eye is clear or until all the 69
solution has been used.
• Instruct the client to close and move the eye periodically to help
move secretions from the upper to the lower conjunctival sac.
14 Clean and dry the eyelids as needed. Wipe the eyelids gently from the inner
to the outer canthus to collect excess medication.
15 Remove and discard gloves. Wash hands.
16 Apply an eye pad if needed, and secure it with paper eye tape.
17 Assess the client’s response immediately after the instillation or irrigation
and again after the medication should have acted.
18 Document all relevant assessments and interventions.
• Name of the drug or irrigating solution
• The strength
• The number of drops if a liquid medication
• The time
• The response of the client
19 Evaluation
• Perform follow-up based on findings of the effectiveness of the
administration or outcomes that deviated from expected or normal
for the client.
• Relate findings to previous data if available
• Report significant deviations from normal to the primary care
provider.
OTIC MEDICATIONS
• Instillations or irrigations of the external auditory canal are carried out for cleaning
purposes.
• Applications of heat and antiseptic solutions are also prescribed.
• Irrigations performed in a hospital require aseptic technique so that microorganisms will
not be introduced into the ear.
• Sterile technique is used if the eardrum is perforated.
• The position of the external auditory canal varies with age.
o Child under 3 years of age, it is directed upward.
o In the adult, the external auditory canal is an S-shaped structure about 2.5 cm long.
• Purpose
o To soften earwax so that it can be readily removed at a later time
o To provide local therapy to reduce inflammation, destroy infective organisms in the
external ear canal, or both
o To relieve pain
NASAL MEDICATIONS
• Nasal instillations usually instilled for their astringent effect to loosen secretions and
facilitate drainage, or to treat infections of the nasal cavity or sinuses.
• Nasal decongestants are the most common nasal instillations.
• Chronic use of nasal decongestants may lead to a rebound effect (an increase in nasal
congestion)
• If excess decongestant solution is swallowed, serious systemic effects may also develop,
especially in children.
• Saline drops are safer as a decongestant for children.
• Clients should blow their noses prior to administration of nasal sprays unless
contraindicated.
• The head tilted back, the client holds the tip of the container just inside the nares and
inhales as the spray enters the nasal passages.
• Clients who use nasal sprays repeatedly, the nares need to be assessed for irritation.
• In children, nasal sprays are given with the head in an upright position to prevent excess
spray from being swallowed.
• Nursing care
o To treat the ethmoid and sphenoid sinuses:
▪ Instruct the client to lie back with the head over
the edge of the bed or a pillow under the shoulders
so that the head is tipped backward.
o To treat the maxillary and frontal sinuses: 74
▪ Instruct the client to assume the same back-lying position, with the head
turned toward the side to be treated.
▪ Advise the client to:
• Breathe through the mouth to prevent
aspiration of medication into the trachea and
bronchi.
• Remain in a back lying position for at least
1 minute so that the solution will come into contact with the entire
nasal surface
• Avoid blowing the nose for several minutes.
VAGINAL MEDICATIONS
• Purposes
o To treat or prevent infection
75
o To reduce inflammation
o To relieve vaginal discomfort
RECTAL MEDICATIONS
• Obtain assistance to immobilize an infant or young child to prevent accidental injury due 79
to sudden movement during the procedure.
• For a child under 3 years of age, the nurse should use the gloved fifth finger for insertion.
• After 3 years of age, the index finger can usually be used.
• For a child or infant, insert a suppository 2 inches or less.
INHALED MEDICATIONS
• Nebulizers
o Nebulizers deliver most medications administered through the inhaled route.
o Used to deliver a fine spray (fog or mist) of medication or moisture to a client.
o Two kinds of nebulization:
▪ Atomization
• A device called an atomizer produces rather
large droplets for inhalation.
▪ Aerosolization
• The droplets are suspended in a gas, such as oxygen.
o The smaller the droplets, the further they can be inhaled into the respiratory tract.
o When a medication is intended for the nasal mucosa, it is inhaled through the nose.
o When a medication is intended for the trachea, bronchi, and/or lungs, it is inhaled
through the mouth.
• Metered-dose inhaler (MDI)
o A handheld nebulizer.
o A pressurized container of medication that can be used by the client to release the
medication through a mouthpiece.
o Client teaching:
▪ Ensure that the canister is firmly and fully inserted into the inhaler.
▪ Remove the mouthpiece cap. Holding the
inhaler upright, shake the inhaler
vigorously for 3 to 5 seconds to mix the
medication evenly.
▪ Exhale comfortably
▪ Hold the canister upside down
• Hold the MDI 1 to 2 inches from the open mouth.
• Or put the mouthpiece far enough into the mouth with its opening 80
toward the throat such that the lips can tightly close around the
mouthpiece.
▪ Press down once on the MDI canister (which releases the dose) and inhale
slowly (for 3 to 5 seconds) and deeply through the mouth.
▪ Hold your breath for 10 seconds or as long as possible to allow the aerosol
to reach deeper airways.
▪ Remove the inhaler from or away from the mouth.
▪ Exhale slowly through pursed lips because controlled exhalation keeps the
small airways open during exhalation.
▪ Repeat the inhalation if ordered. Wait 20 to 30 seconds between inhalations
of bronchodilator medications. The first inhalation has a chance to work and
the subsequent dose reaches deeper into the lungs.
▪ Following use of the inhaler, rinse mouth with tap water to remove any
remaining medication and reduce irritation and of infection.
▪ Clean the MDI mouthpiece after each use. Use mild soap and water, rinse
it, and let it air dry before replacing it on the device.
▪ Store the canister at room temperature.
▪ Avoid extremes of temperature.
▪ Report adverse reactions such as restlessness, palpitations, nervousness, or
rash to the primary care provider.
▪ Many MDIs contain steroids for an anti-inflammatory effect. Prolonged use
increases the risk of fungal infections in the mouth, indicating a need for
attentive mouth care.
81